Issue 2/2019
Content (9 Articles)
Chronic Lymphocytic Leukemia
Leukemia (A Aguayo, Section Editor)
Bispecific Antibodies in Hematologic Malignancies: When, to Whom, and How Should Be Best Used?
Roberta Demichelis-Gómez, Daniela Pérez-Sámano, Christianne Bourlon
Acute Myeloid Leukemia
Leukemia (A Aguayo, Section Editor)
New Treatment Options for Acute Myeloid Leukemia in 2019
Marco Cerrano, Raphael Itzykson
Communicating with Adolescents and Young Adults about Cancer-Associated Weight Loss
Joanne Reid, Clare McKeaveney, Peter Martin
Clonidine
Palliative Medicine (A Jatoi, Section Editor)
Novel Approaches for Treating Pain in Children
William Splinter
Nausea
Palliative Medicine (A Jatoi, Section Editor)
Anticoagulation in Cancer Patients: a Summary of Pitfalls to Avoid
Harsh K. Patel, Alok A. Khorana
Kidney Cancer
Evolving Therapies (RM Bukowski, Section Editor)
Pegylated Interleukin-10: Clinical Development of an Immunoregulatory Cytokine for Use in Cancer Therapeutics
Karen Autio, Martin Oft
Tyrosine Kinase Inhibitors
Evolving Therapies (RM Bukowski, Section Editor)
TRK Inhibitors: Clinical Development of Larotrectinib
Munveer S. Bhangoo, Darren Sigal
Lymphoma
Evolving Therapies (RM Bukowski, Section Editor)
BET and EZH2 Inhibitors: Novel Approaches for Targeting Cancer
Sofia Genta, Maria Cristina Pirosa, Anastasios Stathis
Pyrvinium
Evolving Therapies (RM Bukowski, Section Editor)
Recent Development of Wnt Signaling Pathway Inhibitors for Cancer Therapeutics
Jerry Harb, Pen-Jen Lin, Jijun Hao